Cabozantinib approved for advanced medullary thyroid cancer

被引：21
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2013年 / 70卷 / 02期
关键词：
D O I：
10.2146/news130005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [41] Medullary thyroid cancer
    Clayman, GL
    El-Baradie, TS
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 91 - +
  • [42] Medullary thyroid cancer
    You, Y. Nancy
    Lakhani, Vipul
    Wells, Samuel A., Jr.
    Moley, Jeffrey F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 15 (03) : 639 - +
  • [43] MEDULLARY CANCER OF THE THYROID
    GOSSOT, D
    DUBOST, C
    SARFATI, E
    GAZETTE MEDICALE, 1987, 94 (12): : 59 - &
  • [44] Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer
    Konda, Bhavana
    Sherman, Eric J.
    Massarelli, Erminia
    Nieva, Jorge
    Muzaffar, Jameel
    Morris III, John C.
    Ryder, Mabel
    Ho, Alan L.
    Agulnik, Mark
    Wei, Lai
    Handley, Demond
    Moses, Catherine
    Jacob, Rajani
    Wright, John
    Streicher, Howard
    Carson, William
    Shah, Manisha H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (03): : 830 - 837
  • [45] Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
    Deshpande, Hari
    Marler, Vicky
    Sosa, Julie Ann
    ONCOTARGETS AND THERAPY, 2011, 4 : 209 - 215
  • [46] Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib
    Prete, Alessandro
    Gambale, Carla
    Cappagli, Virginia
    Bottici, Valeria
    Rossi, Piercarlo
    Caciagli, Marco
    Papini, Piermarco
    Taddei, Donatella
    Ortori, Simona
    Gabbrielli, Luciano
    Celi, Alessandro
    Materazzi, Gabriele
    Elisei, Rossella
    Matrone, Antonio
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (06) : 905 - 915
  • [47] Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer
    Sun, Yongkun
    Du, Feng
    Gao, Ming
    Ji, Qinghai
    Li, Zhendong
    Zhang, Yuan
    Guo, Zhuming
    Wang, Jun
    Chen, Xiangjin
    Wang, Jinwan
    Chi, Yihebali
    Tang, Pingzhang
    THYROID, 2018, 28 (11) : 1455 - 1461
  • [48] Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
    Turkdogan, Sena
    Forest, Veronique-Isabelle
    Hier, Michael P.
    Tamilia, Michael
    Florea, Anca
    Payne, Richard J.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 47
  • [49] Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    A. Matrone
    A. Prete
    A. Nervo
    A. Ragni
    L. Agate
    E. Molinaro
    C. Giani
    L. Valerio
    E. Minaldi
    A. Piovesan
    R. Elisei
    Journal of Endocrinological Investigation, 2021, 44 : 2859 - 2859
  • [50] Management of treatment-related toxicities in advanced medullary thyroid cancer
    Brose, Marcia S.
    Bible, Keith C.
    Chow, Laura Q. M.
    Gilbert, Jill
    Grande, Carolyn
    Worden, Francis
    Haddad, Robert
    CANCER TREATMENT REVIEWS, 2018, 66 : 64 - 73
12345